# Tina Vilsbøll

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/tina-vilsb-ll/

## Facts

| Field | Value |
| --- | --- |
| Citations | 36,751 |
| Field | Diabetes Treatment and Management |
| h-index | 88 |
| i10-index | 348 |
| Last Known Institution | University of Copenhagen |
| OpenAlex ID | https://openalex.org/A5004120950 |
| ORCID iD | 0000-0002-0456-6787 |
| Works | 725 |

## Researcher papers

Showing 12 of 14.

- [Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes](https://scholariq.org/papers/semaglutide-and-cardiovascular-outcomes-in-patients-with-type-2-diabetes/)
- [Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes](https://scholariq.org/papers/oral-semaglutide-and-cardiovascular-outcomes-in-patients-with-type-2-diabetes/)
- [Effects of glucagon-like peptide-1 receptor agonists on weight loss: systematic review and meta-analyses of randomised controlled trials](https://scholariq.org/papers/effects-of-glucagon-like-peptide-1-receptor-agonists-on-weight-loss-systematic/)
- [Reduced Postprandial Concentrations of Intact Biologically Active Glucagon-Like Peptide 1 in Type 2 Diabetic Patients](https://scholariq.org/papers/reduced-postprandial-concentrations-of-intact-biologically-active-glucagon-like/)
- [Recovery of gut microbiota of healthy adults following antibiotic exposure](https://scholariq.org/papers/recovery-of-gut-microbiota-of-healthy-adults-following-antibiotic-exposure/)
- [Glucagon-like peptide 1 in health and disease](https://scholariq.org/papers/glucagon-like-peptide-1-in-health-and-disease/)
- [Incretin Secretion in Relation to Meal Size and Body Weight in Healthy Subjects and People with Type 1 and Type 2 Diabetes Mellitus](https://scholariq.org/papers/incretin-secretion-in-relation-to-meal-size-and-body-weight-in-healthy-subjects/)
- [Liraglutide, a Long-Acting Human Glucagon-Like Peptide-1 Analog, Given as Monotherapy Significantly Improves Glycemic Control and Lowers Body Weight Without Risk of Hypoglycemia in Patients With Type 2 Diabetes](https://scholariq.org/papers/liraglutide-a-long-acting-human-glucagon-like-peptide-1-analog-given-as/)
- [Similar Elimination Rates of Glucagon-Like Peptide-1 in Obese Type 2 Diabetic Patients and Healthy Subjects](https://scholariq.org/papers/similar-elimination-rates-of-glucagon-like-peptide-1-in-obese-type-2-diabetic/)
- [Incretins, insulin secretion and Type 2 diabetes mellitus](https://scholariq.org/papers/incretins-insulin-secretion-and-type-2-diabetes-mellitus/)
- [Semaglutide (SUSTAIN and PIONEER) reduces cardiovascular events in type 2 diabetes across varying cardiovascular risk](https://scholariq.org/papers/semaglutide-sustain-and-pioneer-reduces-cardiovascular-events-in-type-2-diabetes/)
- [The effect of exogenous GLP-1 on food intake is lost in male truncally vagotomized subjects with pyloroplasty](https://scholariq.org/papers/the-effect-of-exogenous-glp-1-on-food-intake-is-lost-in-male-truncally/)

## Researcher topics

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Diabetes Management and Research](https://scholariq.org/topics/diabetes-management-and-research/)
- [Pancreatic function and diabetes](https://scholariq.org/topics/pancreatic-function-and-diabetes/)
- [Metabolism, Diabetes, and Cancer](https://scholariq.org/topics/metabolism-diabetes-and-cancer/)
- [Hyperglycemia and glycemic control in critically ill and hospitalized patients](https://scholariq.org/topics/hyperglycemia-and-glycemic-control-in-critically-ill-and-hospitalized-patients/)

## Researcher university

- [University of Copenhagen](https://scholariq.org/institutions/university-of-copenhagen/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.